Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Studying the Impoverishing Effects of Procuring Medicines: A National Study Publisher Pubmed



Amiresmaili M1 ; Emrani Z2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Health Management, Economics and Policy Making, School of Management and Medical Informatics, Kerman University of Medical Sciences, Kerman, Iran
  2. 2. Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Health Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Source: BMC International Health and Human Rights Published:2019


Abstract

Background: One of the main treatment procedures is through medicine prescription. Considering the rising burden of drug costs, we conducted this study to estimate the impoverishing effects of medicine on Iranian households. Method: We carried out calculations based on the Iranian National Household Survey for the year 2013. Amoxicillin, atorvastatin and metformin were the drugs selected. Three different poverty lines were applied. Impoverishment was estimated for various scenarios. Additionally, the associations of some demographic factors were tested. Excel 2013 and SPSS v.19 were used. Results: Many households fell under the poverty line after purchasing drugs. Procuring original brand (OB) drugs caused more poverty than lowest-priced generic (LPG) equivalents. The logistic regression testing showed that the age, gender and literacy of the head of household and the size of the household were associated with impoverishment. Conclusion: This study showed that purchasing medicines increases the impoverishment risk of households. This risk is an index used to assess financial protection against health costs, which is in turn an indicator of health equity. The results will be of practical use for policymakers when addressing different scenarios of setting medicines prices as well as when considering alternatives for cost shifting for cross subsidies in pharmaceutical procurement. © 2019 The Author(s).
Other Related Docs
11. Best Practices in Achieving Universal Health Coverage: A Scoping Review, Medical Journal of the Islamic Republic of Iran (2021)
17. Eliciting Preferences for Health Insurance in Iran Using Discrete Choice Experiment Analysis, International Journal of Health Policy and Management (2019)
18. Policy Options to Reduce Fragmentation in the Pooling of Health Insurance Funds in Iran, International Journal of Health Policy and Management (2016)
20. Future Financing Scenarios for Iran's Healthcare System, Archives of Iranian Medicine (2022)
21. The Effect of Macroeconomic Indicators on Health-Care Expenditure in Iran, Journal of Education and Health Promotion (2019)
26. Decomposition of Health Inequality Determinants in Shiraz, South-West Iran, Journal of Research in Health Sciences (2015)
30. Universal Health Coverage in Iran: Where We Stand and How We Can Move Forward, Medical Journal of the Islamic Republic of Iran (2019)
33. Informal Caregivers in Hospitals: Opportunities and Threats, International Journal of Health Planning and Management (2018)
37. Insecure Employment Contracts During the Covid-19 Pandemic and the Need for Participation in Policy Making, International Journal of Environmental Research and Public Health (2021)
41. Evaluation of Service Quality From Patients' Viewpoint, BMC Health Services Research (2019)
42. Informal Payments for Outpatient Health Care: Country-Wide Evidence From Iran, Medical Journal of the Islamic Republic of Iran (2022)
46. Researchable Clinical Problems From the Viewpoint of Healthcare Providers: A Qualitative Study, Journal of Mazandaran University of Medical Sciences (2019)
50. The Projection of Iran’S Healthcare Expenditures by 2030: Evidence of a Time-Series Analysis, International Journal of Health Policy and Management (2022)